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INTRODUCTION
Although gangliogliomas of the central nervous system
are rather uncommon tumors that consist of a mixture of
neoplastic glial cells and differentiated ganglion cells, the
disease entity is well recognized. They occur most frequent-
ly in children and in adults younger than 30 yr old (1). Gan-
gliogliomas are typically associated with a long history of
intractable seizures because they most often arise in the tem-
poral lobe; the prognosis is usually favorable (1). In contrast,
anaplastic gangliogliomas are very rare and their clinical
course is poorly understood (2-6). The anaplastic change in
gangliogliomas is more frequent in the pediatric population
(3, 6). Here, we report a case of anaplastic ganglioglioma
identified histologically at initial resection in a middle-aged
woman.
CASE REPORT
A 45-yr-old female patient presented with a history of
headache and dizziness, both of which progressed slowly. A
neurological examination showed nothing remarkable. Pre-
operative magnetic resonance imaging (MRI) revealed a left
frontal lesion that was slightly hypointense on T1-weighted
images and hyperintense on T2-weighted images. The lesion
extended to the cingulate gyrus with peritumoral edema and
strong contrast enhancement (Fig. 1A). Gross total resection
of the tumor revealed a dark-brown, friable mass, consisting
of a soft, aspiratable portion and a fibrous hypervascular non-
aspiratable portion. Microscopically, the ganglioglioma con-
tained atypical glial cells and scattered ganglion cells. The
tumor cells infiltrated the gray matter and subarachnoid space
(Fig. 2A). The tumor cells in the gray matter consisted of
neoplastic ganglion cells and glial cells. Those in the sub-
arachnoid space were mainly glial cells and showed increased
cellularity, nuclear atypism, and occasional mitosis (Fig. 2B).
The abnormally clustered ganglion cells lacked orderly dis-
tribution and polarity, and most had large nuclei with promi-
nent nucleoli (Fig. 2C). The neoplastic ganglion cells were
immunoreactive to synaptophysin and neuron specific eno-
lase (NSE) (Fig. 3A, B). The atypical glial components were
positive for glial fibrillary acidic protein (GFAP) (Fig. 3C).
A diagnosis of anaplastic ganglioglioma was made. The pa-
tient recovered postoperatively without any neurologic de-
ficits. MRI taken 12 days postoperatively showed multiple
irregularly shaped enhancing lesions along the resection mar-
gin of the left frontal lobe and cingulate gyrus (Fig. 1B). Two
weeks after surgery, she received one cycle of intravenous
nimustine HCl (ACNU, 60 mg) and cisplatin (CDDP, 60
mg). Subsequently, radiation therapy was administered in
30 doses for a total dose of 6,000 cGy over five weeks, and
additional three cycles of chemotherapy with the same regi-
men were given. During chemotherapy, she was managed
for pancytopenia. Five months later, follow-up MRI revealed
that the remaining mass in the cingulate gyrus and resection
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We report a case of anaplastic ganglioglioma. A 45-yr-old woman was admitted with
a 5-month history of headache and dizziness, both of which progressed slowly. Pre-
operative magnetic resonance imaging revealed a strong enhancing mass in the
left frontal lobe extending to the cingulate gyrus. Adjuvant radiation therapy and
chemotherapy were given after gross total resection of the tumor. Histological and
immunohistochemical studies showed an anaplastic ganglioglioma. Gangliogliomas
of the central nervous system are rather uncommon tumors, and anaplastic ones
are extremely rare. The pertinent literature regarding gangliogliomas is reviewed.
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margin had disappeared (Fig. 1C). She has shown intact neu-
rological status and no other complications until now, and
the last follow-up MRI at 35 months postoperatively demon-
strated no evidence of recurrence (Fig. 1D, E).
DISCUSSION
The incidence of gangliogliomas has been reported to range
from 0.4% to 7.6% in a series of brain tumors in a pediatric
population (7). Central nervous system gangliogliomas are
usually benign. Although malignant variants of ganglioglio-
ma are said to be rare, Russell and Rubinstein estimated the
rate of malignant change to be approximately 10% (1). Con-
sidering other reports, anaplastic gangliogliomas seem to
account for 3-5% of gangliogliomas (6). However, the inci-
dence remains unknown. Although malignant variants com-
monly occur in the supratentorial regions, some occur in
other regions (8-12). Recently, Blumcke and Wiestler (13)
reported that these tumors tend to occur in older patients
with a mean age of 35±14.5 yr (range 10-88 yr). Macrosco-
pically, gangliogliomas are usually firm well-circumscribed
masses with a granular appearance on cut sections (1). Accord-
ing to Russell and Rubinstein (1), the microscopic criteria
for the diagnosis of ganglioglioma are as follows: the tumor
consists of a mixture of glial cells and neurons; the glial cells
consist mostly of astrocytes; and the cells are identified as
neurons only if Nissl substance can be demonstrated by cre-
syl violet staining or if they give rise to neuronal processes,
as demonstrated using modified Bielschowski or Bodian
stains. For neurons to be considered neoplastic, they must
be either clearly heterotopic (located away from the gray mat-
ter), or atypical (showing disorientation, bizarre shapes or
sizes, and nuclei with hyperchromatism and frequent binu-
cleation) (7). Confirmation of the neuronal component may
require the use of immunohistochemical markers, including
synaptophysin, neurofilament protein, NSE (1, 7), and NeuN.
The astroglial components are positive for GFAP and S-100
proteins. In our case, we found neoplastic glial cells and neu-
ronal cells that were clustered and lacked orderly distribu-
tion and polarity; most had large nuclei with prominent nu-
cleoli. The tumor cells revealed definite immunoreactivity
for synaptophysin, NSE, and GFAP. The Ki-67 labeling index
(LI) in our case was 20%, while the reported Ki-67 LI in gan-
glioglioma is generally less than 10% (Fig. 3D) (6). There-
fore, we made a diagnosis of diagnosed anaplastic gangliog-
lioma in our case. 
The manifestation of malignant biological features in some
gangliogliomas, as with other glial tumors, results from ana-
plastic histological features at initial resection (3, 9, 12, 14-
Fig. 1. Preoperative MRI showing an
irregular strong enhancing mass in the
left frontal lobe extending to the cingu-
late gyrus (A). MRI on the 12th postop-
erative day showing multiple irregularly
shaped enhancing lesions along the
resection margin of the left frontal lobe
and cingulate gyrus (B). After chemo-
therapy and radiation therapy, MRI 5
months postoperatively revealed that the
irregular enhancing lesions in the resect-
ed margin of the left frontal lobe and
cingulate gyrus had disappeared (C). And, the last follow-up MRI at 35 months postoperatively shows no evidence of recurrence (D, E).
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Study Age at diagnosis Sex Symptoms Location Treatment
Hall et al. (1986) 6 mo F IICP Frontal OP
Allegraza et al. (1990) 45 yrs F IICP Frontal OP, RT
Campos et al. (1994) 13 yrs M Seizure Temporal OP
Hirose et al. (1997) 12 yrs F Hemiplegia Brainstem OP, RT, CTx
Araki et al. (1999) 53 yrs F Seizure Frontal OP, RT, CTx
Danjoux et al. (2001) 26 yrs M Seizure Temporal OP
Suzuki et al. (2002) 59 yrs M IICP, motor weakness Temporal OP
Nair et al. (2004) 60 yrs M Seizure Parietal OP
Matsuzaki et al. (2005) 64 yrs F Dizziness, ataxia, gait difficulty CPA OP, RT
Table 1. Summary of the reported cases of anaplastic ganglioglioma at initial resection
IICP, increased intracranial pressure; OP, surgery; RT, radiotherapy; CTx, chemotherapy; CPA, cerebellopontine angle.
Fig. 2. Photomicrographs showing the histopathology of the
ganglioglioma in our case. (A) The tumor cells infiltrated the
gray matter and subarachnoid space. The tumor cells in the
gray matter consisted of neoplastic ganglion cells and glial
cells. Those in the subarachnoid space (asterisk) are mainly
glial cells and show increased cellularity, nuclear atypism, and
occasional mitosis (hematoxylin and eosin, original magnifica-
tion, ×40). (B) Atypical glial cells (arrow) and scattered gan-
glion cells (white arrow) constitute the ganglioglioma. Note the
increased cellularity and nuclear atypism of the glial cells (he-
matoxylin and eosin, original magnification, ×400). (C) Neo-
plastic ganglion cells (arrow) are clustered abnormally and
lack orientation and polarity. Most have large nuclei with promi-
nent nucleoli (hematoxylin and eosin, original magnification,
×400).
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Fig. 3. Immunostaining features suggestive of anaplastic gangliogliomas. Neoplastic ganglion cells are positive for NSE (A) and synapto-
physin (B). (C) Glial components are positive for GFAP, and scattered ganglion cells are negative. (D) The Ki-67 LI is high (20%) in the
region of anaplastic transformation.
A B
C D
Study Age at diagnosis (yr) Sex Symptoms Location Treatment
Kitano et al. (1987) 19  F Kyphotic deformity, spastic paraparesis Frontal OP, RT
Jay et al. (1994) 10  M IICP Spinal cord OP, RT, CTx
Sasaki et al. (1996) 26  M Seizure Frontal OP, RT
Kurian et al. (1998) 10  M Hemiparesis Temporal OP, RT
Mittler et al. (1999) 21  M LBP, paresthesia Spinal cord OP, RT
Whittle et al. (2002) 39  M Confusion, seizure Temporal, parietal OP, RT
30  F Seizure Temporal, occipital OP, RT
Di Patre et al. (2004) 42  F Spastic paraparesis Spinal cord OP, RT
Table 2. Summary of the reported cases of anaplastic transformation of a previously benign ganglioglioma
IICP, increased intracranial pressure; LBP, low back pain; OP, surgery; RT, radiotherapy; CTx, chemotherapy; CPA, cerebellopontine angle.19) (Table 1) or anaplastic transformation of a previously
benign ganglioglioma (4, 8, 10, 11, 20-22) (Table 2). These
tumors tend to occur in older patients compared with the
usual onset age of ganglioglioma, especially anaplastic gan-
gliogliomas found at initial resection.
Total removal is recommended and regarded as a good pro-
gnostic factor for the treatment of ganglioglioma without
anaplastic features (2, 5, 7). The benefits of radiation thera-
py or chemotherapy for the treatment of ganglioglioma have
not been clearly defined (4, 7). Although radiation therapy
has uncertain benefits, it is generally given to patients with
incomplete resection of the tumor or recurrent tumor, and
to those with a tumor histology showing anaplastic features
or oligodendroglial-like cells (7). Although the optimum
treatment for anaplastic ganglioglioma has not been estab-
lished, our patient, who was treated surgically with adjuvant
therapy, is still alive without tumor progression or recurrence.
This suggests that adjuvant radiation and chemotherapy is
of some value.
The biological nature of these anaplastic variants is poorly
understood because there are few documented cases. The
survival rate is lower when the tumor is localized in the mid-
line structures or when there are anaplastic features (2, 7, 23).
Based on their multivariate analysis, Park et al. (24) report-
ed that the two most important favorable prognostic factors
affecting the overall survival were low tumor grade and gross
total resection. However, other authors reported that the his-
tological grade of the ganglioglioma is not a predictor of poor
outcome (5, 7). Therefore, the prognosis of gangliogliomas
with malignant histological features remains uncertain. Al-
though predicting the prognosis of anaplastic gangliogliomas
is difficult, some authors stated that cell kinetic studies, such
as MIB-1 staining, may be useful for predicting the progno-
sis (6, 8).
Here, we report on a very rare case of anaplastic gangliog-
lioma that occurred in a middle-aged woman. Although the
relationship between the clinical outcome and histological
grade remains unclear and the effects of radiation therapy
and chemotherapy on gangliogliomas are uncertain, adju-
vant radiation therapy and chemotherapy appear to have been
effective, at least so far. Further long-term studies on a larger
number of ganglioglioma patients are necessary to better
understand the clinical outcome and appropriate treatment
strategies.
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